4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane
C68H73BrN12O4 — CID 158192338
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane
4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane (PubChem CID 158192338) has the molecular formula C68H73BrN12O4 and a molecular weight of 1202.32 g/mol. Its IUPAC name is 4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane.
Molecular Properties
| Compound Name | 4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane |
|---|---|
| PubChem CID | 158192338 |
| Molecular Formula | C68H73BrN12O4 |
| Molecular Weight | 1202.32 g/mol |
| Exact Mass | 1200.51 |
| IUPAC Name | 4-[1-[(4-bromophenyl)methyl]-2-methylimidazo[4,5-b]pyridin-6-yl]-3,5-dimethyl-1,2-oxazole;but-1-ene;3,5-dimethyl-4-[2-methyl-1-[[4-(oxiran-2-ylmethyl)phenyl]methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;3,5-dimethyl-4-[2-methyl-1-[(4-prop-2-enylphenyl)methyl]imidazo[4,5-b]pyridin-6-yl]-1,2-oxazole;methane |
| SMILES | C.C=CCC.C=CCc1ccc(Cn2c(C)nc3ncc(-c4c(C)noc4C)cc32)cc1.Cc1noc(C)c1-c1cnc2nc(C)n(Cc3ccc(Br)cc3)c2c1.Cc1noc(C)c1-c1cnc2nc(C)n(Cc3ccc(CC4CO4)cc3)c2c1 |
| InChI | InChI=1S/C22H22N4O2.C22H22N4O.C19H17BrN4O.C4H8.CH4/c1-13-21(14(2)28-25-13)18-9-20-22(23-10-18)24-15(3)26(20)11-17-6-4-16(5-7-17)8-19-12-27-19;1-5-6-17-7-9-18(10-8-17)13-26-16(4)24-22-20(26)11-19(12-23-22)21-14(2)25-27-15(21)3;1-11-18(12(2)25-23-11)15-8-17-19(21-9-15)22-13(3)24(17)10-14-4-6-16(20)7-5-14;1-3-4-2;/h4-7,9-10,19H,8,11-12H2,1-3H3;5,7-12H,1,6,13H2,2-4H3;4-9H,10H2,1-3H3;3H,1,4H2,2H3;1H4 |
| InChIKey | FZXKVGROKLGFEF-UHFFFAOYSA-N |
| XLogP | 15.83 |
| TPSA | 182.75 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 85 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1202.32 |
| LogP ≤ 5 | 15.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158192338 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.